[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-434372-105":59,"doc-detail-434372-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","corrigendum-to-erianin-serves-as-an-nfatc1-inhibitor-to-prevent-breast-cancer-induced-osteoclastogenesis-and-bone-destruction-apology-for-fig-s2-copy-paste-error-and-corrected-fig-s2","Corrigendum to Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction - Apology for Fig. S2 copy-paste error and corrected Fig. S2","","Corrigendum corrects an issue in the supplementary material of the article “Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction.” The authors state that a copy-paste mistake led to the unintended misplacement of Fig. S2, and they apologize for any inconvenience. The corrected Fig. S2 is provided, showing lower NFATc1 expression associated with longer survival in higher-risk bone metastasis cancer patients, and also the relationship involving RANKL gene expression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/corrigendum-to-erianin-serves-as-an-nfatc1-inhibitor-to-prevent-breast-cancer-induced-osteoclastogenesis-and-bone-destruction-apology-for-fig-s2-copy-paste-error-and-corrected-fig-s2/434372/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/corrigendum-to-erianin-serves-as-an-nfatc1-inhibitor-to-prevent-breast-cancer-induced-osteoclastogenesis-and-bone-destruction-apology-for-fig-s2-copy-paste-error-and-corrected-fig-s2/434372.png","ImageObject",300,407,{"name":92,"@type":93},"Alex Sinclair","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What error is corrected in this corrigendum?","Question",{"text":112,"@type":113},"The authors report an oversight related to Fig. S2 caused by a copy-paste error that resulted in the unintended misplacement of Fig. S2.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the corrected Fig. S2 show?",{"text":117,"@type":113},"The corrected Fig. S2 presents lower NFATc1 expression associated with longer survival of cancer patients with higher risk of bone metastasis, and it also includes the correlation involving RANKL gene expression.",{"name":119,"@type":110,"acceptedAnswer":120},"Where can readers find the original article information?",{"text":121,"@type":113},"The corrigendum includes the DOI of the original article and provides the associated content references, along with correspondence details and the publication license statement.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},434372,1791338871,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":8,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":81,"preview_page_count":4},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Journal of Advanced Research 79 (2026) 974–974  \nContents lists available at ScienceDirect  \nJournal of Advanced Research  \njournal [homepage: www. elsevier. com/locate/jare](homepage: www. elsevier. com/locate/jare)  \nCorrigendum  \nCorrigendum to ‘‘Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction”Adv. Res. 69 (2025) 399-411]  \nJiehuang Zheng a, 1, Weili He c, 1, Yan Chen a, 1, Lihong Li a, Qinghe Liang a, Wenqi Dai a, Ruopeng Li a, Fengsheng Chen a, Ziye Chen a, Yanhui Tan b,⁎, Xiaojuan Li a,⁎  \na Laboratory of Anti-inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China  \nb State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541000, China  \nc Department of Breast Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou 510630, China  \nThe authors regret the oversight related to Fig. S2 due to a copy-paste error which resulted in the unintended misplacement of Fig. S2. The authors would like to apologise for any inconvenience caused.  \nThe corrected Fig. S2 is shown below:  \nFig. S2. Lower expression of NFATc1 was related to longer survival of cancer patients with higher-risk of bone metastasis (A) The correlation between NFATc1 gene expression and survival of cancer patients with high risk of bone metastasis. (B) The correlation between RANKL gene expression and survival of cancer patients with high risk of bone metastasis.  \nDOI of original article: [https://doi.org/10.1016/j.jare.2024.03.021](https://doi.org/10.1016/j.jare.2024.03.021)[ ](https://doi.org/10.1016/j.jare.2024.03.021)⁎ Corresponding authors.  \nE-mail addresses: [tyh533@126.com](tyh533@126.com) (Y. Tan), [lixiaoj@smu.edu.cn](lixiaoj@smu.edu.cn) (X. Li).  \n1 These authors contributed equally to this work.  \n[https://doi.org/10.1016/j.jare.2025.09.035](https://doi.org/10.1016/j.jare.2025.09.035)  \n2090-1232/© 2025 Published by Elsevier B.V. on behalf of Cairo University.  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).","cbCaipfV2wGjohQr","https://ap.wps.com/l/cbCaipfV2wGjohQr","pdf",372696,"English","# Corrigendum\n## Reason for correction\n## Corrected Fig. S2 information","[{\"question\":\"What error is corrected in this corrigendum?\",\"answer\":\"The authors report an oversight related to Fig. S2 caused by a copy-paste error that resulted in the unintended misplacement of Fig. S2.\"},{\"question\":\"What does the corrected Fig. S2 show?\",\"answer\":\"The corrected Fig. S2 presents lower NFATc1 expression associated with longer survival of cancer patients with higher risk of bone metastasis, and it also includes the correlation involving RANKL gene expression.\"},{\"question\":\"Where can readers find the original article information?\",\"answer\":\"The corrigendum includes the DOI of the original article and provides the associated content references, along with correspondence details and the publication license statement.\"}]","Corrigendum to Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction - Apology for Fig. S2 copy-paste error and corrected Fig. S2 | PDF",1790668837]